bioRxiv Science⌕ Search

Biology subjects

Yun, B.

Publications and source records attributed to Yun, B..

3 recordsLinked to original sources

Toward understanding drivers of specialized metabolism in Actinomycetota: insights from 1432 transcriptomics datasets for 132 strains

Actinomycetota are major sources of specialized metabolites with applications in drug discovery and agriculture, yet much of their biosynthetic potential remains silent under standard laboratory conditions. Limited understanding of the mechanisms controlling biosynthetic gene cluster (BGC) activation constrains metabolite discovery and production. Here, we generated 1432 RNA-seq datasets from 132 Actinomycetota strains grown in eight media to identify patterns associated with BGC expression. On average, strains expressed 44% of their encoded BGCs across the tested conditions, with more expression observed among known BGCs (61%) compared to uncharacterized BGCs (35%). Co-expression analyses revealed frequent associations between BGCs and transporters, transcriptional regulators, and proteins containing DUF397 and DUF742 domains. Targeted overexpression of candidate genes selected from BGC-associated co-expression modules increased metabolite production, with DUF397- and DUF742-containing operons showing the broadest effects by boosting the levels of several different specialized metabolites. Other genes boosted levels in a metabolite-specific manner. Together, our results support a multilayered model of BGC regulation in Actinomycetota in which BGC expression is shaped by medium composition, BGC-specific regulators, and integration of BGCs into broader transcriptional network modules. By connecting BGC expression to specific media and co-expressed genes, this study also provides a resource for selecting growth conditions and engineering specialized metabolism.

microbiology↗

Non-invasive diagnosis of early chronic colitis cancerization via amplified sensing of miRNA-21 in NIR-IIb window

Early diagnosis of the colitis-associated colorectal cancer (CRC) is of great significance for improving prognosis and survival rates. However, the clinical used colonoscopy and biopsy methods are invasive and lack of sensitivity at early stage of cancerization. Herein, we present an amplified sensing strategy in the second near-infrared b (NIR-IIb, 1500-1700 nm) window for non-invasive in situ visualization of early cancerization biomarker miRNA-21. A CRC nanosensor composed of Er3+ doped lanthanide nanoparticles, DNAzyme, and IR820 dye is designed as a NIR-IIb ratiometric luminescence reporter, providing rapid feedback and high sensitive miRNA-21 detection with limit of detection (LOD) of 1.26 pM. This strategy enables a non-invasive detection of colitis-associated cancerization up to [~]4 weeks ahead of the clinically used biopsy analysis, providing a promising alternative for early diagnosis of chronic colitis cancerization and guidance for therapeutic management.

bioengineering↗

Noninvasively real-time monitoring in-vivo immune cell and tumor cell interaction by NIR-II nanosensor

Immunocytotherapy holds significant promise as a novel cancer treatment, but its effectiveness is often hindered by delayed responses, requiring evaluations every two to three weeks based on current diagnostic methods. Early assessment of immune cell-tumor cell interactions could provide more timely insights into therapeutic efficacy, enabling adjustments to treatment plans. In this study, we report a noninvasive nanosensor (C8R-DSNP) for real-time monitoring of in vivo immune cell activities in the second near-infrared long-wavelength (NIR-II-L) window (1500-1900 nm), which offers deep tissue transparency. The C8R-DSNP responds rapidly to caspase-8, a key apoptotic signaling molecule generated during interactions between natural killer (NK-92) immune cells and tumor cells. Using ratiometric NIR-II-L fluorescence imaging, we captured dynamic in vivo observations of NK-92 cell engagement with tumor cells in a mouse model. These results demonstrated cancer cell apoptosis that happens as early as 4.5 hours after NK-92 cell infusion. Additionally, in vitro urine imaging confirmed the initiation of apoptosis via cleaved fluorescent small molecules, while single-cell tracking within blood vessels and tumors further elucidated immune cell dynamics. This real-time NIR-II-L monitoring approach offers valuable insights for optimizing immunocytotherapy strategies.

bioengineering↗